isocoumarins has been researched along with Skin Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hur, JS; Kim, JC; Lee, W; Paik, MJ; Zhao, L | 1 |
Kim, CH; Ko, SH; Kwak, YS; Lee, KH; Lee, WY; Lim, DS; Yoon, WH | 1 |
2 other study(ies) available for isocoumarins and Skin Neoplasms
Article | Year |
---|---|
A Multifunctional and Possible Skin UV Protectant, (3R)-5-Hydroxymellein, Produced by an Endolichenic Fungus Isolated from Parmotrema austrosinense.
Topics: Animals; Anti-Infective Agents; Antioxidants; Ascorbic Acid; Biphenyl Compounds; Butylated Hydroxyanisole; Candida albicans; Cell Line; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Isocoumarins; Keratinocytes; Lichens; Lipid Peroxidation; Melanins; Melanoma, Experimental; Mice; Picrates; Saccharomycetales; Skin Neoplasms; Sunscreening Agents; Superoxides | 2016 |
Topoisomerase I inactivation by reticulol and its in vivo cytotoxicity against B16F10 melanoma.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Coumarins; DNA Topoisomerases, Type I; Doxorubicin; Drug Therapy, Combination; Female; Injections, Intravenous; Isocoumarins; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Phosphodiesterase Inhibitors; Skin Neoplasms; Topoisomerase I Inhibitors | 2003 |